Technical Analysis for BRTXQ - Biorestorative Therapies Inc

Grade Last Price % Change Price Change
grade F 0.0001 -50.00% -0.0001
BRTXQ closed down 50.0 percent on Thursday, April 9, 2020, on 3.48 times normal volume.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A N/A Down
Historical BRTXQ trend table...

Date Alert Name Type % Chg
Lizard Bearish Bearish Day Trade Setup 0.00%
Volume Surge Other 0.00%
Doji - Bearish? Reversal 0.00%
Doji - Bullish? Reversal 0.00%
Lizard Bullish Bullish Day Trade Setup -50.00%
Doji - Bearish? Reversal -50.00%
Doji - Bullish? Reversal -50.00%
Doji - Bearish? Reversal -50.00%
Doji - Bullish? Reversal -50.00%
Doji - Bearish? Reversal -50.00%
Older signals for BRTXQ ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

BioRestorative Therapies, Inc. develops therapeutic products using cell and tissue protocols primarily involving adult stem cells. The company's two core programs are relate to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program includes a lead cell therapy candidate, BRTX-100 is a product formulated from autologous (or a person's own) cultured mesenchymal stem cells collected from the patient's bone marrow and intended for the non-surgical treatment of painful lumbosacral disc disorders. The BRTX-100 utilizes proprietary technology and involves collecting a patient's bone marrow, isolating and culturing stem cells from the bone marrow, and cryopreserving the cells. In an outpatient procedure, BRTX-100 is to be injected by a physician into the patient's damaged disc and treatment is intended for patients whose pain has not been alleviated by non-invasive procedures and who potentially face the prospect of surgery. The company have received authorization from the Food and Drug Administration to commence a Phase 2 clinical trial using BRTX-100to treat persistent lower back pain due to painful degenerative discs. The company is also developing Metabolic Program (ThermoStem), a cell-based therapy in preclinical stage to target obesity and metabolic disorders using brown adipose (fat) derived stem cells to generate brown adipose tissue (BAT). In addition, the company provides investigational curved needle device designed to deliver cells and/or other therapeutic products or material to the spine and discs. BioRestorative Therapies, Inc. has a research and development agreement with Rohto Pharmaceutical Co., Ltd.; and a research agreement with Pfizer, Inc. and the University of Pennsylvania. The company was formerly known as Stem Cell Assurance, Inc. and changed its name to BioRestorative Therapies, Inc. in August 2011. BioRestorative Therapies, Inc. was incorporated in 1997 and is based in Melville, New York. On March 20, 2020, BioRestorative Therapies, Inc., filed a voluntary petition
Biotechnology Branches Of Biology Life Sciences Biology Pain Surgery Stem Cells Cell Therapy Cell Biology Food And Drug Administration Obesity Endocrine System Therapeutic Products Metabolic Disorders Skeletal System Back Pain Bone Marrow Adult Stem Cell Bone Therapeutic Invasive Procedures University Of Pennsylvania Disc/Spine Disease The University Of Pennsylvania Tissue Protocols Treatment Of Disc/Spine Disease

Is BRTXQ a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Recent News

Indicators

Indicator Value
52 Week High 0.0002
52 Week Low 0.0001
Average Volume 12,701,170
200-Day Moving Average 0.0000
50-Day Moving Average 0.0000
20-Day Moving Average 0.0000
10-Day Moving Average 0.0002
Average True Range 0.0000
ADX 0.0
+DI 0.0000
-DI 0.0000
Chandelier Exit (Long, 3 ATRs ) N/A
Chandelier Exit (Short, 3 ATRs ) N/A
Upper Bollinger Band 0.0000
Lower Bollinger Band 0.0000
Percent B (%b) 0.0
BandWidth 0.0000
MACD Line 0.0000
MACD Signal Line 0.0000
MACD Histogram 0.0
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.0003
Resistance 3 (R3) 0.0003 0.0002 0.0002
Resistance 2 (R2) 0.0002 0.0002 0.0002 0.0002
Resistance 1 (R1) 0.0002 0.0002 0.0002 0.0002 0.0002
Pivot Point 0.0001 0.0001 0.0001 0.0001 0.0001
Support 1 (S1) 0.0001 0.0001 0.0001 0.0001 0.0000
Support 2 (S2) 0.0000 0.0001 0.0000 0.0000
Support 3 (S3) 0.0000 0.0000 0.0000
Support 4 (S4) -0.0001